NUVB
Nuvation Bio Inc.
NYSE · Healthcare · Biotechnology · US
$6.81
+0.59%Margins
Gross margin
93.9%
EBITDA margin
-74.8%
EBIT margin
-81.0%
Net margin
-88.2%
FCF margin
-48.7%
-59.0%
Return on equity
-20.1%
Return on assets
-27.2%
Return on invested capital
0.25x
Asset turnover
-$82.6M
Cash from operations
$1.88
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026